141
Views
6
CrossRef citations to date
0
Altmetric
Review

Current progress in the development of a prophylactic vaccine for HIV-1

&
Pages 9-26 | Published online: 22 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lorenzo Antonio Ramirez, Tatiana Arango & Jean Boyer. (2013) Therapeutic and prophylactic DNA vaccines for HIV-1. Expert Opinion on Biological Therapy 13:4, pages 563-573.
Read now

Articles from other publishers (5)

Aitana Almodóvar-Payá, Mónica Villarreal-Salazar, Noemí de Luna, Gisela Nogales-Gadea, Alberto Real-Martínez, Antoni L. Andreu, Miguel Angel Martín, Joaquin Arenas, Alejandro Lucia, John Vissing, Thomas Krag & Tomàs Pinós. (2020) Preclinical Research in Glycogen Storage Diseases: A Comprehensive Review of Current Animal Models. International Journal of Molecular Sciences 21:24, pages 9621.
Crossref
Franco Pissani, Bianca Schulte, Michael A. Eller, Bruce T. Schultz, Silvia Ratto-Kim, Mary Marovich, Prasert Thongcharoen, Somchai Sriplienchan, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Stefan Esser, Galit Alter, Merlin L. Robb, Jerome H. Kim, Nelson L. Michael & Hendrik Streeck. (2018) Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans. Journal of Virology 92:23.
Crossref
Byoung-Jun Kim, Bo-Ram Kim, Yoon-Hoh Kook & Bum-Joon Kim. (2018) Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine. Frontiers in Immunology 9.
Crossref
Nadia Chanzu & Beatrice Ondondo. (2014) Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy. Frontiers in Immunology 5.
Crossref
Anton V. Borovjagin, Jorge G. Gomez-Gutierrez, Haval Shirwan & Qiana L. Matthews. 2014. Novel Technologies for Vaccine Development. Novel Technologies for Vaccine Development 203 271 .